Video Module

Idiopathic Thrombocytopenic Purpura: Shifting the Treatment Paradigm

Source: Idiopathic Thrombocytopenic Purpura (ITP): Shifting the Treatment Paradigm*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Idiopathic Thrombocytopenic Purpura: Shifting the Treatment Paradigm

Faculty:

Howard Liebman, MD

CREDIT INFORMATION

Release Date: 01/15/10

Expiration Date: 01/14/11

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Examine the benefits and adverse effects of standard treatment strategies for ITP
Employ recently approved therapies into the treatment plan for patients with ITP
Formulate treatment strategies for individual ITP patients based on expert opinion and recently updated guidelines

CCO Video Module contain video commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.